HITT for the Identification of Mild Traumatic Brain Injury
NCT: NCT05092282 · COMPLETED
Brief Summary
Rebion has developed a device, the Rebion trauma tool (referred to as the head and intraocular trauma tool, or "HITT"), that detects ocular fixation and alignment using a binocular retinal scan. Preliminary data obtained from hospitalized patients with a clinically-confirmed traumatic brain injury (TBI) and uninjured controls indicates that the device can detect changes in ocular fixation, alignment, and saccades that are related to brain injury. This study seeks to evaluate the ability of the Rebion trauma tool to assess perturbations in eye movements resulting from TBI. The study will enroll 100 TBI patients and 100 controls.
Frequently Asked Questions
What is HITT for the Identification of Mild Traumatic Brain Injury?
HITT for the Identification of Mild Traumatic Brain Injury is a clinical trial registered under NCT05092282. Current status: COMPLETED.
What is the status of NCT05092282?
The current status of NCT05092282 (HITT for the Identification of Mild Traumatic Brain Injury) is: COMPLETED.
When did HITT for the Identification of Mild Traumatic Brain Injury start?
HITT for the Identification of Mild Traumatic Brain Injury started on 2021-08-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.